Biotech

All Articles

Vertex, hammered through AATD once again, loses 2 properties on discard pile

.Vertex's try to manage an unusual hereditary disease has actually struck an additional obstacle. Th...

Vir gains 3 T-cell engagers coming from Sanofi, lays off 25% of staff

.Vir Medical's second-quarter earnings report had not been except significant headlines. The company...

Galapagos pauses CAR-T cell therapy hearing over Parkinsonism instance

.Galapagos has stopped briefly application in a test of a BCMA-directed CAR-T tissue treatment, push...

James Wilson leaving Penn to launch two new biotechs

.After greater than thirty years, genetics therapy trendsetter James Wilson M.D., Ph.D., is leaving ...

3 biotechs make an effort to trump the summer heat by dropping staff

.As biotechs attempt to turn a fresh web page in August, at the very least 3 companies have actually...

venBio elevates $528M for 5th life scientific researches VC fund

.Professional venture capital company venBio has actually elevated another half a billion dollars to...

Otsuka spends $800M for Jnana and its clinical-stage PKU medicine

.Otsuka Drug has picked up Boston-based Jnana Therapies for $800 million so the Japanese biotech can...

FibroGen lays off 75% of US team as property flunks 2 additional tests

.FibroGen is drastically restructuring its service, giving up 75% of its united state personnel and ...

Tracon relax weeks after injectable PD-L1 prevention fail

.Tracon Pharmaceuticals has actually determined to wane operations weeks after an injectable immune ...

Ideaya bags possibility on Biocytogen bispecific ADC in $400M deal

.Ideaya Biosciences is actually betting $400 million in biobucks that a bispecific antibody-drug con...